摘要
目的:研究中西医结合分期论治的综合治疗方案防治痛风性关节炎的临床疗效,探索痛风性关节炎更安全、有效、合理的治疗方案。方法:将166例痛风患者随机分成3组:中药组58例、西药组56例和中西药组52例,连续观察12周。急性期中药组予虎杖痛风颗粒、金黄膏,西药组予双氯芬酸钠双释放肠溶胶囊;间歇期中药组予茵连痛风颗粒,西药组予苯溴马隆片或别嘌呤醇片;中西药组予中药组和西药组药物。观察整个治疗期间临床症状积分、血尿酸、显效时间、复发率、愈显率和不良反应发生率等指标。结果:在急性期,3组愈显率和显效时间比较,差异无统计学意义;3组临床症状积分和血尿酸水平降低,但差异无统计学意义。在间歇期,西药组、中西药组血尿酸水平明显降低,而中药组血尿酸水平虽有下降趋势,但差异无统计学意义。中药组复发率为12.07%,西药组为26.79%,中西药组为9.62%;中药组复发时平均症状积分为(10.00±3.61)分,西药组为(12.38±1.85)分,中西药组为(10.75±1.89)分。3组复发率和复发时的症状积分比较,差异有统计学意义。中药组不良反应发生率为3.45%,西药组为21.43%,中西药组为15.38%,3组间不良反应发生率比较,差异有统计学意义。结论:中西医结合分期综合防治方案既能安全、有效地控制痛风性关节炎急性期症状,恢复关节功能,又能有效地控制间歇期血尿酸水平,预防急性发作,减轻不良反应。
Objective： To evaluate the clinical therapeutic effect of the combination therapy of traditional Chinese and Western medicines in treating gouty arthritis based on the stage of disease, and to explore a safe. effective and reasonable therapeutic regimen for prevention and treatment of gouty arthritis. Methods： One hundred and sixty-six cases of gouty arthritis were divided into three groups randomly. 58 cases in traditional Chinese drug （TCD）-treated group, 56 cases in Western medicine （WM）-treated group and 52 cases in TCD plus WM-treated group. They were all treated for 12 weeks. In the acute stage, patients in TCD-treated group were treated with Huzhang Gout Granule and Jinhuang Ointment, and patients in WM-treated group were treated with diclofenac sodium dual release enteric-coated capsules. In the intermission, patients in TCD-treated group were given Yinlian Gout Granule. and patients in WM-treated group were given benzbromarone or allopurinol. Patients in TCD plus WM-treated group were given both TCD and WM. Clinical symptom score and blood uric acid （BUA） level were measured. The effect initiating time, relapse rate, efficacy rate and the incidence rate of adverse effects were also studied. Results： There were no significant differences in the efficacy rate and effect initiating time among the three groups in the acute stage. The clinical symptom score and BUA level were obviously reduced in three groups. In the intermission, BUA level in the WM-treated group and TCD plus WM-treated group were obviously reduced. Although there was a drop tendency in the BUA level in TCD-treated group, there was no statistical difference. The relapse rates in TCD-, WM- and TCD plus WM-treated groups were 12.07%, 26.79% and 9.62%, respectively. There was statistical difference in relapse rates among the three groups （P〈0.05）. The relapse rate was decreased in TCD plus WM-treated group as compared with those in TCD-treated and WM-treated groups. The average clinical symptom scores during recurrence i
出处
《中西医结合学报》
CAS
2008年第6期576-580,共5页
Journal of Chinese Integrative Medicine
基金
上海市中医特色专科建设资助项目
上海市中医临床优势专病建设资助项目(No.2006YSZB003)
关键词
痛风性关节炎
中西医结合疗法
临床研究
随机对照试验
gouty arthritis
integrated traditional Chinese and Western medicine therapy
clinical research
randomized controlled trial
